Introduction
Chryseobacterium species are a group of non-motile, catalase-positive, oxidase-positive, indole-positive and nonglucose-fermenting Gram-negative bacilli. The genus Chryseobacterium includes six species that were previously designated as members of the genus Flavobacterium. 1 C. gleum and C. indologenes, formerly known as Flavobacterium CDC group IIb, have been clearly differentiated by DNA-DNA homology and eight phenotypic characteristics. 2 C. meningosepticum and C. indologenes are two species commonly isolated from clinical specimens with C. meningosepticum the most pathogenic member of the genus. However, the clinical significance of C. indologenes has not been fully established because this bacterium is not frequently recovered from clinical specimens. C. indologenes is a rare pathogen in humans and is not normally present in the human microflora although it is widely distributed in nature. 3 To the best of our knowledge, there are only 42 reported cases of C. indologenes bacteremia in the literature, with most cases reported in Taiwan. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] In this study, we analyzed 16 patients with C. indologenes bacteremia in our institute over a 4-year period. We highlighted the clinical features of C. indologenes bacteremia as well as the antimicrobial susceptibility pattern of this pathogen.
Methods

Patient identification
Patients with C. indologenes bacteremia were identified retrospectively from blood culture reports, from the clinical microbiology laboratory at Taipei Veterans General Hospital (TVGH) between January 1, 2004 and January 31, 2008. The TVGH is a medical center and teaching hospital with a capacity of 2,900 beds in northern Taiwan.
All medical records of patients whose blood cultures positive for C. indologenes were reviewed retrospectively. Patients younger than 18 years of age were excluded. There was no apparent outbreak of C. indologenes infection during the time of our study.
Definitions
An episode of significant bacteremia was defined as one or more blood cultures positive for C. indologenes together with clinical sepsis. Bacteremia without clinical sepsis was considered contamination and was excluded. Nosocomial bacteremia was defined as bacteremia occurring ≥ 48 hours after admission, or bacteremia for which the patient had been hospitalized at any time within the previous month. Central venous catheter (CVC)-related bacteremia was recorded when C. indologenes was isolated simultaneously from blood and either the tip of the catheter or purulent discharge from the CVC site, or there was a positive blood culture for C. indologenes with the presence of inflammation at the CVC site without another identifiable source of infection. Prolonged antibiotic use defined as administration of intravenous antibiotics for more than 14 days within a 30-day period prior to the diagnosis of bacteremia. Immunosuppressive therapy was defined as the use of cytotoxic agents or corticosteroids (> 30 mg prednisolone daily or equivalent for ≥ 1 week). Neutropenia defined as an absolute neutrophil count less than 500/μL. Recent surgery defined as a surgical procedure performed within 1 month prior to the onset of C. indologenes bacteremia. Appropriate antibiotic therapy defined as the use of at least one intravenous antibiotic to which the microorganism was susceptible according to minimum inhibitory concentration (MIC) testing within 72 hours of the diagnosis of bacteremia. Death was considered to have been related to bacteremia if the patient died ≤ 14 days after the onset of bacteremia and if no other cause of death was identified.
C. indologenes remain unclear, with our study revealing favorable outcomes of C. indologenes bacteremia. Epidemiological surveillance of this organism in Taiwan and extensive worldwide surveillance programs are required.
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Microbiology
Blood culture samples were processed using the BACTEC NR-660 instrument (Becton Dickinson, Sparks, MD, USA). All positive cultures were examined following Gram staining and were subcultured on blood agar plates and eosinmethylene blue agar plates for further identification. All isolates were oxidase-positive Gram-negative rods that did not ferment glucose. The ID32 GN system (bioMérieux, Marcy l'Etoile, France) was used for identifying C. indologenes. All blood culture isolates were stored at -70°C and these frozen stocks were subcultured twice before further confirmation. The VITEK 2 system (bioMérieux) with a VITEK 2 GN card was used to confirm bacterial identification according to the manufacturer's instructions.
The MIC values for bacteremic isolates of C. indologenes were performed using the VITEK 2 system with an AST GN-09 card following the manufacturer's instructions. The breakpoints of MICs for susceptibility were determined by applying the Clinical and Laboratory Standards Institute (CLSI) standards for susceptibility for Pseudomonas aeruginosa and non-Enterobacteriaceae. 13 
Results
Bacterial isolates
Sixteen isolates of C. indologenes were initially identified by the ID32 GN system during the study period. The VITEK 2 system with a VITEK 2 GN card was used to confirm the identity of bacteria. All 16 microorganisms were identified as C. indologenes.
Clinical characteristics
Sixteen significant episodes of C. indologenes bacteremia in 16 patients were identified during the study period. The clinical characteristics of the 16 patients with C. indologenes bacteremia are summarized in Tables 1 and 2 . Male patients predominated (75%), and the mean age of affected patients was 66 years (range, 44-86 years), with seven patients older than 80 years.
Underlying diseases were present in all patients and all bacteremic episodes were nosocomial. Two patients (12.5%) had polymicrobial bacteremia and C. indologenes was also isolated simultaneously from other sites in two patients. Of the 16 patients, 13 patients had associated conditions, including central venous catheterization (n = 7), indwelling urinary catheter (n = 7), immunosuppression (n = 5), prolonged antibiotics use (n = 5), ventilator use (n = 3), neutropenia (n = 3), recent surgery (n = 2), intensive care unit admission (n = 2), total parenteral nutrition (n = 1), percutaneous nephrostomy (n = 1) and jejunostomy (n = 1). The most common clinical manifestation was primary bacteremia. In addition to the 12 patients with primary bacteremia, two patients had catheter-related bacteremia and one patient had urinary tract infection and peritonitis.
Three patients (18.8%) were treated with antibiotics appropriate to the MIC test results; their condition improved within 5 days of the initiation of treatment. Of the 13 patients not treated with appropriate antibiotics, 10 patients improved within 7 days of the initiation of antibiotics. The CVC was removed from the two patients not treated with appropriate antibiotics for catheterrelated bacteremia. Two patients died within 14 days after the onset of bacteremia. One patient (patient 13) died of acute myocardial infarction on the second day of admission; therefore, the clinical response to antibiotics could not be determined. Only one patient (6.3%) not treated with appropriate antibiotics fulfilled the definition of bacteremia-related mortality. Bacteremia occurred on the 58 th day of hospitalization and he received antibiotics for a prolonged period before the onset of bacteremia. Sepsis progressed despite treatment with cefepime and he died on the 12 th day after bacteremia onset.
Antimicrobial susceptibility
The results of susceptibility testing with antimicrobial agents are shown in Table 3 . Our isolates were susceptible to trimethoprim-sulfamethoxazole (75.0%), levofloxacin (62.5%), ciprofloxacin (43.8%), piperacillin-tazobactam (50.0%) and cefepime (12.5%), but at various levels. All isolates were resistant to other β-lactam antibiotics and aminoglycosides.
Discussion
C. indologenes is widely distributed in nature but is a rare human pathogen. It has been isolated from clinical specimens but rarely from blood 3 and has been shown to cause a variety of invasive infections, such as primary bacteremia, catheter-related bacteremia, wound sepsis, cellulitis, pyonephrosis, peritonitis, biliary tract infection and ventilator-associated pneumonia. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] In the hospital environment, it is frequently recovered from wet surfaces and water systems by virtue of its ability to contaminate and persist in fluid-containing apparatuses. 12 It is interesting to note that infections caused by C. indologenes have been reported mainly from patients in Taiwan. [3] [4] [5] 8 However, studies aimed at epidemiological surveillance of this organism in various hospitals in Taiwan are lacking, and further molecular typing of these isolates may help us elucidate the linkage of nosocomial infection.
In the literature, most cases of C. indologenes bacteremia were detected in hospitalized patients with a severe underlying disease, such as malignancies or diabetes mellitus, or indwelling devices. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] In the present report, the majority of underlying diseases were malignancy, diabetes mellitus, hypertension, congestive heart failure and chronic kidney disease greater than stage 3. The mean age of our patients was 66 years, which is older than in a previous report (50.5 years). 5 Male were predominant in our study, and this finding is compatible with previous reports. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Twelve of the 16 patients had undergone various invasive procedures, such as central venous catheterization, urinary catheterization, respiratory assistance or recent surgery. It was uncertain as to whether these procedures were responsible for bacteremia, and it may suggest that a breakdown of infection control techniques was a likely cause of infection. As a result, we suggest that C. indologenes should be included in the list of pathogens that cause bacteremia in immunocompromised hosts, patients with multiple comorbidities, patients who have undergone various invasive procedures and patients who received antibiotics over a prolonged period during hospitalization. In the present study, bacteremia were nosocomially acquired and most bacteremia (11/16) developed at least 10 days after admission. This finding was consistent with the literature that most cases of C. indologenes bacteremia were due to nosocomial infection. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Hsueh et al found nosocomial pneumonia and catheter-related bacteremia accounted for most cases. [3] [4] [5] In this series, primary bacteremia was the most common clinical syndrome, accounting for 75.0% (12/16) of cases. Although the portal of bacteremia was not clearly defined in most patients, it may be the result of insufficient microbiological study and the retrospective characteristic of this study. Most bacteremia developed when the CVC was kept in place and catheter-related bacteremia may be underestimated in our study. The production of biofilm on foreign materials and protease activity may play an important role in the virulence of invasive infections due to C. indologenes. 13 The choice of an effective drug for the empirical treatment of infections due to C. indologenes is sometimes difficult due to the limited data in the literature. In addition, the results of susceptibility testing vary when different methods are used. However, in vitro susceptibilities determined by the disk diffusion method showed poor correlation compared with the broth microdilution method, which is the preferred methodology. [15] [16] [17] The MIC breakpoints for these organisms have not been established by the CLSI. 14 Nearly uniform resistance to extended-spectrum penicillins, first-and second-generation cephalosporins, ceftriaxone, aztreonam, ticarcillin-clavulanate, imipenem, meropenem, chloramphenicol, erythromycin and aminoglycosides has been reported. Piperacillin-tazobactam, piperacillin, cefoperazone, ceftazidime, cefepime, cefpirome, minocycline, rifampicin and trimethoprim-sulfamethoxazole, however, are usually effective. 5, [15] [16] [17] According to the results obtained from the SENTRY Antimicrobial Surveillance Program, the newer fluoroquinolones (garenoxacin, gatifloxacin and levofloxacin) may represent the most appropriate antimicrobial agents to treat C. indologenes infections. C. indologenes is usually resistant to imipenem due to constitutive production of metallo-β-lactamase. 17 In this study, C. indologenes isolates showed various susceptibilities to trimethoprim-sulfamethoxazole, levofloxacin, ciprofloxacin, piperacillin-tazobactam and cefepime. All of the isolates were resistant to other β-lactam antibiotics and aminoglycosides, which was in accordance with previous reports. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 17 However, contrary to previous reports, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 17 all our isolates were resistant to ceftazidime and piperacillin. Cefepime exhibited poor activity (12.5% susceptible) against these pathogens, which was significantly lower. Among the β-lactams, the most active agent overall was piperacillin-tazobactam (50% susceptible), which showed a much lower susceptibility rate. Our analysis showed that trimethoprim-sulfamethoxazole (75% susceptible) was the most potent agent against the overall collection of C. indologenes. Fluoroquinolones also showed lower activity (ciprofloxacin 43.8% susceptible, levofloxacin 62.5% susceptible) than in the SENTRY Antimicrobial Surveillance Program (ciprofloxacin 85% susceptible, levofloxacin 100.0% susceptible). However, only one report on the treatment of C. indologenes infection with newer fluoroquinolones was identified in the literature; this case was treated with levofloxacin successfully. 6 Further research is required to define the role of newer fluoroquinolones in the treatment of C. indologenes infections. Our study revealed an increased rate of resistance in C. indologenes to previously potent antibiotics. We have two explanations for this phenomenon. First, the age of patients in our series was older than in previous reports. [3] [4] [5] 17 Marchaim et al described an increase in the incidence and resistance of Gram-negative organisms causing bacteremia, concomitant with older patients. 18 Second, our anal- In the present study, our patients received antibiotics on the basis of the results of the routinely used disk diffusion test, and the appropriate use of antibiotics was judged according to MIC testing. Although most of our patients did not receive appropriate antibiotics according to MIC testing, they recovered from C. indologenes bacteremia and only one patient died. This patient had been subject to prolonged antibiotic usage hospitalization before the onset of bacteremia. Multiple indwelling devices were kept in place in this patient, possibly implying that the production of a biofilm on foreign materials contributed to invasive disease and poor outcome. In other literature, the mortality attributable to C. indologenes-related infections was around 14-17%. [3] [4] [5] In one study, only one-third of the patients infected with C. indologenes received appropriate antibiotics according to MIC testing. 5 Although our data showed a lower rate (18.8%) of appropriate antibiotic usage according to MIC testing, our data implied a favorable outcome of C. indologenes bacteremia. Additionally, our study revealed that the outcome of C. indologenes bacteremia was not principally influenced by the antibiotic itself. Underlying immune defenses and other associated clinical conditions may determine the prognosis of C. indologenes bacteremia. The possibility exists that these are cases of pseudobacteremia due to contamination by C. indologenes during the management of blood cultures. However, this possibility is difficult to verify, especially in patients with severely debilitating diseases. 5 Hsueh et al indicated that indwelling-device-related infections caused by C. indologenes did not always require removal of devices. In his report, six of seven patients were successfully treated with appropriate antibiotics when the devices were kept in place. 3 Two patients in our study with catheter-related bacteremia were successfully treated without appropriate antibiotics against C. indologenes when the catheter was removed. Due to the wide range of antibiotic resistance and difficulty in determining optimal therapeutic regimens, we suggest that indwelling devices should be removed as soon as possible if indwelling device-related C. indologenes infection is suspected.
In conclusion, despite the limited case numbers in this study, it serves as the largest analysis of clinical and microbiological data on C. indologenes bacteremia over the last 10 years. The pathogenicity and factors for virulence of C. indologenes remain unclear, yet our data implied a favorable outcome of bacteremia. The source of bacteremia has not yet been clearly identified. The risk factors for C. indologenes bacteremia included invasive procedures, immunosuppression, neutropenia and prolonged use of antibiotics. The unique resistance of this organism to multiple antibiotics makes it difficult to determine the optimal therapeutic option. Newer fluoroquinolones and trimethoprimsulfamethoxazole may represent the most appropriate antimicrobial agents to treat infections caused by this pathogen. Further studies aimed at epidemiological surveillance of this organism in Taiwan are essential to clarify the linkage to nosocomial infections. Furthermore, extensive worldwide surveillance programs are vital to the formulation of appropriate antimicrobial therapies and understanding the clinical context in which this rare pathogen is isolated. 18 
